Top compounds associated with response to CYB5D1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	1e-05
mRNA	BRD-K97651142	CTRPv2	pan-cancer	AAC	0.15	0.0001
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.14	0.0002
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0006
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0007
mRNA	selumetinib:tretinoin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0008
mRNA	Doxorubicin	gCSI	pan-cancer	AAC	0.17	0.001
mRNA	Dasatinib	CTRPv2	pan-cancer	AAC	-0.12	0.001
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.001
mRNA	Sunitinib	CTRPv2	pan-cancer	AAC	-0.11	0.001

Download CSV